InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Farquharson Andrew, Director. Director active across 1 company, notably Rani Therapeutics Holdings, Inc.. Aggregated, 4 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €733k. History available since 3 February 2022. The latest transaction was filed on 23 August 2022 (C). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Andrew Farquharson is a Director at Rani Therapeutics Holdings, Inc. He plays a key role in the governance of the company, bringing his experience and knowledge in the biotechnology sector. His involvement helps guide strategic decisions.